USA FINANCIAL FORMULAS’s Jazz Pharmaceuticals JAZZ Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	+1,008	New	+$221K	0.04%	114

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

USA FINANCIAL FORMULAS's JAZZ Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1,008 shares worth $243K. The stake represents 0.04% of the portfolio and ranks #114 among its holdings.

239 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

USA FINANCIAL FORMULAS held 1,008 shares of Jazz Pharmaceuticals worth $243K as of Q2 2026.
Jazz Pharmaceuticals was a new USA FINANCIAL FORMULAS position in Q2 2026.
Jazz Pharmaceuticals made up 0.04% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #114 holding.
239 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.